Translational Development Acquisition (TDAC) Shares Outstanding (2023 - 2026)

Translational Development Acquisition's Shares Outstanding history spans 4 years, with the latest figure at $4.7 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $4.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.7 million, a 0.0% change, with the full-year FY2025 number at $4.7 million, changed 0.0% from a year prior.
  • Shares Outstanding came in at $4.7 million for Q1 2026, roughly flat from $4.7 million in the prior quarter.
  • The five-year high for Shares Outstanding was $4.7 million in Q4 2023, with the low at $4.7 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $4.7 million across 4 years, with a median of $4.7 million in 2023.
  • Peak annual rise in Shares Outstanding hit 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Shares Outstanding stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then changed by 0.0% to $4.7 million in 2025, then changed by 0.0% to $4.7 million in 2026.
  • Business Quant data shows Shares Outstanding for TDAC at $4.7 million in Q1 2026, $4.7 million in Q4 2025, and $4.7 million in Q3 2025.